Market revenue in 2023 | USD 3.6 million |
Market revenue in 2030 | USD 6.5 million |
Growth rate | 8.8% (CAGR from 2023 to 2030) |
Largest segment | Phase iii |
Fastest growing segment | Phase I |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Phase I, Phase II, Phase III, Phase IV |
Key market players worldwide | Thermo Fisher Scientific Inc, IQVIA Holdings Inc, Clara Health, Antidote Health, BBK Worldwide, Clariness, Costas Inc, Worldwide Clinical Trials, Veristat, Elligo Health Research |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial patient recruitment services market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 58.33% in 2023. Horizon Databook has segmented the Mexico clinical trial patient recruitment services market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico is an attractive destination for outsourcing clinical trials as cost plays a major factor. Moreover, the proximity to the U.S. and the availability of investigators in urban areas also help reduce costs. A large population cannot typically afford advanced treatments for chronic diseases and may prefer participating in clinical trials.
Hence, the availability of a diverse patient pool is one of the major drivers of the market. The establishment of a regulatory entity called the Federal Commission for the Protection against Sanitary Risk (COFEPRIS) and shortening the setup time for clinical trials to 2 months have attracted more clients to the country.
In addition, high investment in infrastructure development to provide better facilities in the country is expected to drive the market. Mexico is also one of the preferred countries in Latin America to conduct clinical trials owing to the costefficiency & efficacy associated with clinical studies conducted across the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico clinical trial patient recruitment services market , including forecasts for subscribers. This country databook contains high-level insights into Mexico clinical trial patient recruitment services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account